AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 7th, 2019 • Geron Corp • Pharmaceutical preparations • California
This Amended and Restated Employment Agreement (the “Agreement”) is made effective as of the 31st day of January, 2019 (the “Effective Date””), by and between Stephen N. Rosenfield (“Executive”) and Geron Corporation, a Delaware corporation (the “Company”).
Geron Corporation Option Agreement (Nonstatutory Stock Option)Option Agreement • March 7th, 2019 • Geron Corp • Pharmaceutical preparations
Pursuant to your Stock Option Grant Notice (“Grant Notice”) and this Option Agreement, Geron Corporation (the “Company”) has granted you an option under its 2018 Equity Incentive Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. The option is granted to you effective as of the date of grant set forth in the Grant Notice (the “Date of Grant”). If there is any conflict between the terms in this Option Agreement and the Plan, the terms of the Plan will control. Capitalized terms not explicitly defined in this Option Agreement or in the Grant Notice but defined in the Plan will have the same definitions as in the Plan.
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 7th, 2019 • Geron Corp • Pharmaceutical preparations • California
This Amended and Restated Employment Agreement (the “Agreement”) is made effective as of January 31, 2019 (the “Effective Date”), by and between Olivia K. Bloom (“Executive”) and Geron Corporation, a Delaware corporation (the “Company”).
GERON CORPORATION PERFORMANCE-VESTING OPTION AGREEMENT (INCENTIVE STOCK OPTION OR NONSTATUTORY STOCK OPTION)Performance-Vesting Option Agreement • March 7th, 2019 • Geron Corp • Pharmaceutical preparations
Pursuant to your Stock Option Grant Notice (“Grant Notice”) and this Option Agreement, Geron Corporation (the “Company”) has granted you an option under its 2018 Equity Incentive Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. The option is granted to you effective as of the date of grant set forth in the Grant Notice (the “Date of Grant”). If there is any conflict between the terms in this Option Agreement and the Plan, the terms of the Plan will control. Capitalized terms not explicitly defined in this Option Agreement or in the Grant Notice but defined in the Plan will have the same definitions as in the Plan.
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 7th, 2019 • Geron Corp • Pharmaceutical preparations • California
This Amended and Restated Employment Agreement (this “Agreement”) is entered into as of January 31, 2019 (the “Effective Date”), by and between John A. Scarlett, M.D. (“Executive”) and Geron Corporation, a Delaware corporation (the “Company”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 7th, 2019 • Geron Corp • Pharmaceutical preparations • California
This Amended and Restated Employment Agreement (the "Agreement") is made effective as of January 31, 2019 (the "Effective Date"), by and between Melissa A. Kelly Behrs ("Executive") and Geron Corporation, a Delaware corporation (the "Company").
WORK ORDER #1Work Order • March 7th, 2019 • Geron Corp • Pharmaceutical preparations
This Work Order #1 (the “Work Order”) is by and between GERON Corporation (“Client”) and PAREXEL International (IRL) Limited (“PAREXEL”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 7th, 2019 • Geron Corp • Pharmaceutical preparations • New York
This Employment Agreement (“Agreement”) is made effective as of January 15, 2019, (the “Effective Date”), by and between Aleksandra Rizo, M.D., Ph.D. (“Executive”) and Geron Corporation, a Delaware corporation (the “Company”).
GERON CORPORATION PERFORMANCE-VESTING OPTION AGREEMENT (NONSTATUTORY STOCK OPTION)Performance-Vesting Option Agreement (Nonstatutory Stock Option) • March 7th, 2019 • Geron Corp • Pharmaceutical preparations
Pursuant to your Stock Option Grant Notice (“Grant Notice”) and this Option Agreement, Geron Corporation (the “Company”) has granted you an option under its 2018 Inducement Award Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. The option is granted to you effective as of the date of grant set forth in the Grant Notice (the “Date of Grant”). If there is any conflict between the terms in this Option Agreement and the Plan, the terms of the Plan will control. Capitalized terms not explicitly defined in this Option Agreement or in the Grant Notice but defined in the Plan will have the same definitions as in the Plan.
MASTER SERVICES AGREEMENTMaster Services Agreement • March 7th, 2019 • Geron Corp • Pharmaceutical preparations • New York
This Master Services Agreement (this “Agreement”) is effective as of January 30, 2019 (the “Effective Date”), and is by and between Geron Corporation (“Client”), a Delaware corporation with a principal place of business at 149 Commonwealth Drive, Menlo Park, CA 94025, United States, and PAREXEL International (IRL) Limited (“PAREXEL”), a corporation organized under the laws of Ireland with a registered address at 70 Sir John Rogerson’s Quay, Dublin 2, Ireland.
